Market Overview

Cancer Genetics Names John Pappajohn Chairman of the Board of Directors


Cancer Genetics (Nasdaq: CGIX) today announced that its board of directors appointed John Pappajohn as its new Chairman, effective January 6, 2014.

Mr. Pappajohn is a recognized business leader and a pioneer in the venture capital industry. He has been involved in over 100 start-up companies, over 50 IPOs, and has served as a director of over 40 public companies, many in the bioscience and health-related industries. Mr. Pappajohn is a shareholder of CGI and has been a member of its board of directors since 2008.

See full press release

Posted-In: News Guidance Management Global


Related Articles (CGIX)

View Comments and Join the Discussion!

Partner Center